English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Antitumor Activities of tRNA-Derived Fragments and tRNA Halves from Non-pathogenic Escherichia coli Strains on Colorectal Cancer and Their Structure-Activity Relationship Journal article
Cao, Kai Yue, Pan, Yu, Yan, Tong Meng, Tao, Peng, Xiao, Yi, Jiang, Zhi Hong. Antitumor Activities of tRNA-Derived Fragments and tRNA Halves from Non-pathogenic Escherichia coli Strains on Colorectal Cancer and Their Structure-Activity Relationship[J]. mSystems, 2022, 7(2).
Authors:  Cao, Kai Yue;  Pan, Yu;  Yan, Tong Meng;  Tao, Peng;  Xiao, Yi; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.0/6.1 | Submit date：2023/01/30
Antitumor Activity  Chemical Modifications  Gut Microbiota  Trf  
Methylaervine as Potential Lead Compound Against Cervical Carcinoma: Pharmacologic Mechanism Prediction based on Network Pharmacology Journal article
Dan, Wenjia, Xu, Yujie, Gu, Hongling, Gao, Jixiang, Dai, Jiangkun. Methylaervine as Potential Lead Compound Against Cervical Carcinoma: Pharmacologic Mechanism Prediction based on Network Pharmacology[J]. Current Computer-Aided Drug Design, 2022, 18(1), 73-80.
Authors:  Dan, Wenjia;  Xu, Yujie;  Gu, Hongling;  Gao, Jixiang;  Dai, Jiangkun
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:1.5/1.5 | Submit date：2022/03/28
Methylaervine  Synthesis  Antitumor Activity  Adme Study  Network Pharmacology  Docking  
Development of arteannuin B sustained-release microspheres for anti-tumor therapy by integrated experimental and molecular modeling approaches Journal article
Wang, Yanqing, Huang, Weijuan, Wang, Nannan, Ouyang, Defang, Xiao, Lifeng, Zhang, Sirui, Ou, Xiaozheng, He, Tingsha, Yu, Rongmin, Song, Liyan. Development of arteannuin B sustained-release microspheres for anti-tumor therapy by integrated experimental and molecular modeling approaches[J]. PHARMACEUTICS, 2021, 13(8), 1236.
Authors:  Wang, Yanqing;  Huang, Weijuan;  Wang, Nannan;  Ouyang, Defang;  Xiao, Lifeng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:4  IF:4.9/5.5 | Submit date：2021/12/08
Antitumor Activity  Arteannuin b  Microsphere  Molecular Modeling  Pharmacokinetics  Plga  Sustained Release  
The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression Journal article
Gao W., Lin Z., Chen M., Yang X., Cui Z., Zhang X., Yuan L., Zhang Q.. The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression[J]. International Journal of Nanomedicine, 2014, 9(1), 3425-3437.
Authors:  Gao W.;  Lin Z.;  Chen M.;  Yang X.;  Cui Z.; et al.
Favorite | TC[WOS]:19 TC[Scopus]:19 | Submit date：2018/12/27
Antitumor Activity  Cyclosporine a  Liposomes  Low-p-gp-expressing Tumor  Targeted Delivery  
Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin Journal article
Han W., Wang S., Liang R., Wang L., Chen M., Li H., Wang Y.. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin[J]. International Journal of Nanomedicine, 2013, 8, 2187.
Authors:  Han W.;  Wang S.;  Liang R.;  Wang L.;  Chen M.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:24  IF:6.6/7.5 | Submit date：2018/10/31
Antitumor Activity  Cantharidin  Non-ionic Surfactant Vesicle  Toxicity  
Polymeric micelles drug delivery system in oncology Journal article
Gong, J (Gong, Jian), Chen, MW (Chen, Meiwan), Zheng, Y (Zheng, Ying), Wang, SP (Wang, Shengpeng, Wang, YT (Wang, Yitao). Polymeric micelles drug delivery system in oncology[J]. JOURNAL OF CONTROLLED RELEASE, 2012, 159(3), 312-323.
Authors:  Gong, J (Gong, Jian);  Chen, MW (Chen, Meiwan);  Zheng, Y (Zheng, Ying);  Wang, SP (Wang, Shengpeng;  Wang, YT (Wang, Yitao)
View | Adobe PDF | Favorite | TC[WOS]:462 TC[Scopus]:501  IF:10.5/10.6 | Submit date：2018/11/01
Accelerated Blood Clearance  Cell Lung-cancer  Pegylated Liposomal Doxorubicin  Albumin-bound Paclitaxel  Acid) Block-copolymer  Phase-ii Trial  Metastatic Breast-cancer  Metal Complex Micelle  In-vivo Evaluation  Antitumor-activity  
Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo Journal article
Chen C., Zhou H., Xu L., Xu D., Wang Y., Zhang Y., Liu X., Liu Z., Ma D., Ma Q., Chen Y.. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo[J]. Apoptosis, 2010, 15(7), 805-813.
Authors:  Chen C.;  Zhou H.;  Xu L.;  Xu D.;  Wang Y.; et al.
Favorite | TC[WOS]:41 TC[Scopus]:45 | Submit date：2019/01/16
Antitumor Activity  Apoptosis  Chondrosarcoma  Cisplatin  Pdcd5  
Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo Journal article
Wang J., He M., Shi W., Sha H., Feng J., Wang S., Wang Y.. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo[J]. Cancer Investigation, 2009, 27(3), 244-250.
Authors:  Wang J.;  He M.;  Shi W.;  Sha H.;  Feng J.; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8 | Submit date：2019/01/16
Antitumor Activity  Ciks  Gallbladder Cancer  Icos Modification